About FDA
New Technologies/Methodologies to Assess Chemical Food Safety
Description: CFSAN scientists are developing/using established medium throughput biomarker assays and in vivo model systems to assess the safety of food and dietary supplement ingredient/contaminants and to assess the ability of the in vitro systems to predict toxicity (predictive modeling) in vivo. It is our hope that the identification and verification, of medium throughput screening methods via in vivo testing will improve toxicity characterization, increase efficiency, reduce cost as well as refine, reduce or replace animal use.
Briefing Status: ON TRACK
Prior Briefing Status: ON TRACK
Milestone Description | Milestone Date | Milestone Status | Milestone Completion Date |
---|---|---|---|
A. Findings of the in vitro assays will be compared with the in vivo systems to assess the ability of the in vitro systems to predict toxicity in vivo |
|
||
i. Comparison of in vitro renal toxicity results with in vivo results and assessment of the ability of the in vitro renal toxicity test system to predict toxicity in vivo |
6/1/2017 |
Completed | 6/1/2017 |
ii. Comparison of in vitro cardiotoxicity results with in vivo results and assessment of the ability of the in vitro cardiotoxicity test system to predict toxicity in vivo |
6/1/2017 |
Completed | 6/1/2017 |
iii. Provide all results to the Program Office |
7/1/2018 |
On Hold |
Key Projects Legend
Milestone Status | Definition |
---|---|
Not Yet Started | Work for specific milestone has not yet been started. |
Completed | Milestone and/or overall project is completed. |
On Track | Milestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status. |
On Hold | Milestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status. |
Delayed | Milestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status. |